Quorum sensing in Acinetobacter: An emerging pathogen

Critical Reviews in Microbiology

Volumn 36, Issue 4, 2010, Pages 349-360

  Bhargava, Nidhi ^a   Sharma, Prince ^a   Capalash, Neena ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

AbaI; AbaR; Acyl homoserine lactone; Nosocomial infection; Pathogenicity; Virulence

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ABAI; PROTEIN ABAR; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; BACTERIAL STRAIN; BACTERIAL VIRULENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUORUM SENSING; REVIEW; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ACYL-BUTYROLACTONES; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BIOFILMS; CROSS INFECTION; GENE EXPRESSION REGULATION, BACTERIAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; QUORUM SENSING; SEQUENCE ALIGNMENT; VIRULENCE FACTORS;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BURKHOLDERIA AMBIFARIA; HALOTHIOBACILLUS NEAPOLITANUS;

EID: 77958050359     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2010.512269     Document Type: Review

References (92)

1. Adonizio A, Kong K, Mathee K. (2008). Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeru-ginosa by South Florida Plant Extracts. Antimicrob Agents Chemother, 198-203.
2. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B. (2002). Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol, 40, 685-686.
3. Babic F, Venturi V, Maravic-Vlahovicek G. (2010). Tobramycin at subin-hibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate. BMC Infect Dis, 2, 10, 148.
4. Bassler BL. (2002). Small Talk. Cell, 109, 4, 421-424.
5. Bergogne-Berezin E, Friedman H, Bendinelli M. (2008). Acinetobacter Biology and Pathogenesis. New York, USA: Springer Science+Business Media.
6. Birck C, Malfois M, Svergun D, Samama J. (2002). Insights into signal transduction revealed by the low resolution structure of the FixJ response regulator. J Mol Biol, 16;321(3):447-57.
7. Bjarnsholt T, Givskov M. (2007). Quorum-sensing blockade as a strategy for enhancing host defence against bacterial pathogens. Phil Trans R Soc B, 362, 1213-1222.
8. Bonomo RA, Szabo D. (2006). Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis, 43, 49-56.
9. Briggs S, Ellis-Pegler R, Raymond N, Tomas M, Wilkinson L. (2004). Gram-negative bacillary meningitis after cranial surgery or trauma in adults. Scand J Infect Dis, 36, 165-173.
10. Camporese A, Balick MJ, Arvigo R, Esposito RG, Morsellino N, De Simone F, Tubaro A. (2003). Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J. Ethnopharmacol, 87, 1, 103-7.
11. Centre for Disease Control and Prevention. Acinetobacter bauman-nii infections among patients at military medical facilities treating injured US service members 2002-2004. MMWR 2004, 53, 1063-1066.
12. Choi AHK, Slamti L, Avci FY, Pier GB, Litram TM. (2009). Te pgaA-BCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N- Acetylglucosamine, which is critical for bioflm formation. J Bacteriol, 191, 19, 5953-5963.
13. Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, Kim SA, Lee SK, Lee JC. (2005). Outer membrane protein 38 of Acinetobacter bau-mannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol, 7, 1127-1138.
14. Corpet F. (1988). Multiple sequence alignment with hierarchical clustering. Nucl Acid Res, 16, 22, 10881-90.
15. Corrigan KM, Harmis NY, Willcox MD. (2001). Association of Acinetobacter species with contact lens-induced adverse responses. Cornea, 20, 463-466.
16. Cowan MM. (1999). Plant products as antimicrobial agents. Clin Microbiol Rev, 12, 4, 564-582
17. Cza'ra'n T, Hoekstra RF. (2009). Microbial Communication, Cooperation and Chatting: Quorum Sensing Drives the Evolution of Cooperation in Bacteria. PloS ONE, 4, 8, e6655.
18. Devine JH, Countryman C, Baldwin TO. (1988). Nucleotide sequence of the luxR and luxI genes and structure of the primary regulatory region of the regulon of Vibrio fscheri ATCC 7744. Biochem, 27, 837-842.
19. Diggle SP, Crusz SA, Camara M. (2007). Quorum sensing. Curr Biol, 17, R907-R910.
20. Dong Y, Zhang L. (2005). Quorum Sensing and Quorum-Quenching Enzymes. J Microb, 43, 101-109.
21. Dorsey CW, Beglin MS, Actis LA. (2003). Detection and Analysis of Iron Uptake Components Expressed by Acinetobacter baumannii Clinical Isolates. J Clin Microbiol, 41, 9, 4188-4193.
22. Ducros VMA, Lewis RJ, Verma CS, Dodson EJ, Leonard G, Turkenburg GP, Murshudov GN, Wilkinson AJ, Brannigan JA. (2001). Crystal structure of GerE, the ultimate transcriptional regulator of spore formation in Bacillus subtilis. J Mol Biol, 306, 759-771.
23. Egland KA, Greenberg EP. (2001). Quorum sensing in Vibrio fscheri: analysis of the LuxR DNA binding region by alanine-scanning mutagenesis. J Bacteriol, 183, 1, 382-6.
24. Felsenstein J. (1985). Confdence limits on phylogenies: An approach using the bootstrap. Evol, 39, 783-791.
25. Fournier PE, Richet H. (2006). Te epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis, 42, 692-699.
26. Gaddy JA, Actis LA. (2009). Regulation of Acinetobacter baumannii bioflm formation. Future Microbiol, 4, 273-278.
27. Gaddy JA, Tomaras PA, Actis LA. (2009). Te Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Bioflm Formation on Abiotic Surfaces and in the Interaction of this Pathogen with Eukaryotic Cells. Infect Immun, 77, 8, 3150-3160.
28. Gao B., Mohan R., Gupta RS. (2009). Phylogenomics and protein signatures elucidating the evolutionary relationships among the Gammaproteobacteria. Int J Syst Evol Microbiol 59, 234-247.
29. Garcia A, Solar H, González C, Zemelman R. (2000). Efect of EDTA on the resistance of clinical isolates of Acinetobacter bauman-nii to the bactericidal activity of normal human serum. J Med Microbiol, 49, 1047-1050.
30. Gnanamani A, Priya KS, Radhakrishna N, Babu M. (2003). Antibacterial activity of two plant extracts on eight burn pathogens. J. Ethnopharmacol, 86, 59-61.
31. Gonzalez RH, Dijkshoorn L, Van den Barselaar M, Nudel C. (2009). Quorum sensing signal profle of Acinetobacter and environmental sources. Rev argent microbial, 41.
32. Gonzalez RH, Nusblat A, Nudel BC. (2001). Detection and characterization of quorum sensing signal molecules in Acinetobacter strains. Microbiol Res, 155, 271-277.
33. Gould TA, Schwelaer HP, Churchill MEA. (2004). Structure of the Pseudomonas aeruginosa acyl-homoserine lactone synthase LasI. Mol Microbiol, 53, 4, 1135-1146.
34. Grotiuz G, Sirok A, Gadea P, Varela G, Schelotto F. (2006). Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea. J Clin Microbiol, 44, 3838-3841.
35. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, Schembri MK, Song Z, Kristofersen P, Manefeld M, Costerton JM, Molin S, Eberl L, Steinberg P, Kjelleberg S, Huiby N, Givskov M. (2003). Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J, 22, 3803-3815.
36. Irie Y, Parsek MR. (2008).Quorum sensing and microbial bioflms. Curr Top Microbiol Immunol, 322, 67-84.
37. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. (1998). Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol, 36, 7, 1938-41.
38. Joly-Guillou ML. (2005). Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect, 11, 868-873.
39. Kappstein I, Grundmann H, Hauer T, Niemeyer C. (2000). Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients. J Hosp Infect, 44, 27-30.
40. Kau HC, Tsai CC, Kao SC, Hsu WM, Liu JH. (2002). Corneal ulcer of the side port after phacoemulsifcation induced by Acinetobacter baumannii. J Cataract Refract Surg, 28, 895-897.
41. Khan MSA, Zahin M, Hasan S, Hussain FM, Ahmad I. (2009). Inhibition of quorum sensing regulated bacterial functions by plant essential oils with special reference to clove oil. Lett Appl Microbiol, 49, 3, 354-360.
42. Kurcik-Trajkovska B. (2009). Acinetobacter spp. - A serious enemy threatening hospitals worldwide. Maced J Med Sci, 2, 2, 157-162.
43. La Scola B, Fournier PE, Brouqui P, Raoult D. (2001). Detection and culture of Bartonella Quintana, Serratia marscesens and Acinetobacter spp. from decontaminated human body lice. J Clin Microbiol, 39, 1707-1709.
44. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY, Cho D T, Kim J. (2008). Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form bioflm and adhere to epithelial cell surfaces. Clin Microbiol Infect, 14, 1, 49-54.
45. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R. (2006). Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol, 157, 360-366.
46. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF. (2006). Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest, 129, 102-109.
47. Levy J, Oshry T, Rabinowitz R, Lifshitz T. (2005). Acinetobacter cor-neal graft ulcer and endophthalmitis: report of two cases. Can J Opthalmol, 40, 79-82.
48. Limsuwan S, Subhadhirasakul S, Voravuthikunchai PS. (2009). Medicinal plants with signifcant activity against important pathogenic bacteria. Pharm Biol, 47, 8, 683-689.
49. Linde HJ, Hahn J, Holler E, Reischl U, Lehn N. (2002). Septicemia due to Acinetobacter junii. J Clin Microbiol, 40, 2696-2697.
50. Loehfelm TW, Luke NR, Campagnari AA. (2008). Identifcation and characterization of an Acinetobacter baumannii bioflm-associ-ated protein. J Bacteriol, 190, 1036-1044.
51. Lopes JM, Goulart EM, Starling CE. (2007). Pediatric mortality due to nosocomial infection: a critical approach. Braz J Infect Dis, 11, 5, 515-9.
52. Maragakis LL, Perl TM. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis, 46, 8, 1254-63.
53. Marchaim D, Navon-Venezia S, Leavitt A, Chmelnitsky I, Schwaber MJ, Carmeli Y. (2007). Molecular and epidemiologic study of poly-clonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect Control Hosp Epidemiol, 28, 8, 945-50.
54. Maris AE, Sawaya MR, Kaczor-Grzeskowiak M, Jarvis MR, Bearson SMD, Kopka ML, Schroder T, Gunsalus RP, Dickerson RE. (2002). Dimerization allows DNA target site recognition by the NarL response regulator. Nat Struct Biol, 9, 10, 771-778.
55. Metan G, Alp E, Aygen B, Sumerkan B. (2007). Acinetobacter bauman-nii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother, 60, 197-199.
56. Munoz-Price LS, Weinstein RA. (2008). Acinetobacter infection. N Engl J Med, 358, 12, 1271-81.
57. Murray CK, Yun HC, Grifth ME, Hospenthal DR, Tong MJ. (2006). Acinetobacter infection: what was the true impact during the Vietnam confict? Clin Infect Dis, 43, 383-384.
58. Niu C, Clemmer KM, Bonomo RA, Rather PN. (2008). Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J.Bacteriol, 190, 9, 3386-92.
59. Obana Y. (1986). Pathogenic signifcance of Acinetobacter calcoace-ticus: analysis of experimental infection in mice. Microbiol Immunol, 30, 645-657.
60. Palabiyikoglu I, Tekeli E, Cokca F, Akan O, Unal N. (2006). Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect, 62, 94-97.
61. Panilaitis B, Johri A, Blank W, Kaplan D, Fuhrman J. (2002). Adjuvant activity of emulsan, a secreted lipopolysaccharide from Acinetobacter calcoaceticus. Clin Diagn Lab Immunol, 9, 1240-1247.
62. Pappas KM, Weingart CL, Winans SC. (2004). Chemical communication in proteobacteria: biochemical and structural studies of signal synthases and receptors required for intercellular signalling. Mol Microbiol 53, 3, 755-69.
63. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. (2007). Global changes of multidrug-resistant Acinetobacter bau-mannii. Antimicrob Agents Chemther, 51, 3471-3484.
64. Petersen K, Riddle MS, Danko JR, Blazes DL, Hayden R. (2007). Trauma-related infections in battlefeld casualties from Iraq. Ann Surg, 245, 803-811.
65. Pristovsek P, Sengupta K, Lohr F, Schafer B, von Trebra MW, Ruterjans H, Bernhard F. (2003). Structural analysis of the DNA-binding domain of the Erwinia amylovora RcsB protein and its interaction with the RcsAB box. J Biol Chem, 278, 20, 17752-17759.
66. Qi C, Malczynski M, Parker M, Scheetz MH. (2008). Characterization of genetic diversity of carbapenem-resistant Acinetobacter bauman-nii clinical strains collected from 2004 to 2007. J Clin Microbiol, 46, 3, 1106-9.
67. Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9, 117-128.
68. Rasmussen TB, Manefeld M, Andersen JB, Eberl L, Anthoni U, Christophersen C, Steinberg P, Kjelleberg S and Givskov M. (2000). How Delisea pulchra furanones afect quorum sensing and swarming motility in Serratia liquefaciens MG1. Microbiol.146:3237-3244.
69. Rathinavelu S, Zavros Y, Merchant JL. (2003). Acinetobacter lwofi infection and gastritis. Microbes Infect, 5, 651-657.
70. Reimmann C, Beyeler M, Latif A, Winteler H, Foglino M, Lazdunsk A, Haas D. (1997). Te global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide and lipase. Mol Microbiol, 24, 309-319.
71. Saitou N, Nei M. (1987). Te neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol, 4, 406-425.
72. Schlegel A, Böhm A, Lee SJ, Peist R, Decker K, Boos W.(2002).Network regulation of the Escherichia coli maltose system. J Mol Microbiol Biotechnol 4, 3, 301-7.
73. Scott P, Deye G, Srinivasan A, Murray C, Moran K. (2007). An outbreak of multidrug-resistant Acinetobacter baumannii-calcoace-ticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis, 44, 1577-1584.
74. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. (2007).New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyro-sequencing and transposon mutagenesis. Genes Dev, 21, 601-614.
75. Smith RS, Iglewski BH. (2003). Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest, 112, 10, 1460-5.
76. Sperandio V. (2007). Novel approaches to bacterial infection therapy by interfering with bacteria-to-bacteria signalling. Expert Rev Anti Infect Ter, 5, 2, 271-6.
77. Surette MG, Miller MB, Bassler BL. (1999). Quorum sensing in Escherichia coli, Salmonela typhimurium, and Vibrio harvey: a new family of genes responsible for autoinducer production. PNAS (USA), 16, 96, 4, 1639-44.
78. Swift S, Winson MK, Chan PF, Bainton NJ, Birdsall M, Reeves PJ, Rees CED, Chhabra SR, Hill PJ, Troup JP, Bycroft BW, Salmond GPC, Williams p, Stewart GSAB. (1993). A novel strategy for the isolation of luxI homologues:evidence for the widespread distribution of a LuxR: LuxI superfamily in enteric bacteria. Mol Microbiol, 10, 511-520.
79. Tamura K, Dudley J, Nei M, Kumar S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol, 24, 1596-1599.
80. Tamura K, Nei M, Kumar S. (2004). Prospects for inferring very large phylogenies by using the neighbor-joining method. PNAS (USA), 101, 11030-11035.
81. Troup JP, Camara M, Briggs GS, Winson MK, Chhabra SR, Bycroft BW, Williams P, Stewart GS. (1995). Characterization of the yenI/yenR locus from Yersinia enterocolitica mediating the synthesis of two N-acylhomoserine lactone signal molecules. Mol Microbiol, 17, 2, 345-56.
82. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. (2003). Attachment to and bioflm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiol, 149, 3473-3484.
83. Tomaras A P, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. (2008). Characterization of a two-component regulatory system from Acinetobacter baumannii that controls bioflm formation and cellular morphology. Microbiol, 154, 3398-3409.
84. Trottier V, Segura PG, Namias N, King D, Pizano LR. (2007). Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res, 28, 248-254. (Pubitemid 46411561)
85. Uroz S, Dessaux Y, Oger P. (2009). Quorum Sensing and Quorum Quenching: Te Yin andYang of Bacterial Communication. ChemBioChem, 10, 205-216.
86. Vannini A, Volpari C, Gargioli C, Muraglia E, Cortese R, De Francesco R, Neddermann P, Marco SD. (2002). Te crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA. EMBO J, 21, 4393-4401.
87. Venturi V, Subramoni S. (2009). Future research trends in the major chemical language of bacteria. HFSP J, 3, 2, 105-16.
88. Water CM, Bassler BL. (2005). Quorum Sensing: Cell-to-Cell Communication in Bacteria. Annu Rev Cell Dev Biol, 21, 319-346.
89. Whitehead NA, Barnand AM, Slater H, Simpson NJ, Salmond GP. (2001). Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev, 25, 4, 365-404.
90. Wisplinghof H, Bischof T, Tallent SM, Seifert H, Wenzel RP. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis, 39, 309-317.
91. Yavankar SP, Pardesi KR, Chopade BA. (2007). Species distribution and physiological characterization of Acinetobacter genospecies from healthy human skin of tribal population in India. Indian J Med Microbiol, 25, 4, 336-45.
92. Young DM, Parke D, Ornston LN. (2005).Opportunities for genetic investigation aforded by Acinetobacter baylyi, a nutritionally versatile bacterial species that is highly competent for natural transformation. Ann Rev Microbiol, 59, 519-551.